Outcomes following implantable cardioverter-defibrillator generator replacement in patients with recovered left ventricular systolic function: The National Cardiovascular Data Registry.
暂无分享,去创建一个
J. Curtis | Yongfei Wang | K. Minges | J. Hsu | Vincent Y. See | I. Thomas
[1] J. Messenger,et al. Trends in U.S. Cardiovascular Care: 2016 Report From 4 ACC National Cardiovascular Data Registries. , 2017, Journal of the American College of Cardiology.
[2] J. Skinner,et al. Use of Guideline-Directed Medications for Heart Failure Before Cardioverter-Defibrillator Implantation. , 2016, Journal of the American College of Cardiology.
[3] Akshay S. Desai,et al. Angiotensin-neprilysin inhibition versus enalapril in heart failure. , 2014, The New England journal of medicine.
[4] S. Dixit,et al. Appropriateness of primary prevention implantable cardioverter-defibrillators at the time of generator replacement: are indications still met? , 2014, Journal of the American College of Cardiology.
[5] B. French,et al. Heart Failure With Recovered Ejection Fraction: Clinical Description, Biomarkers, and Outcomes , 2014, Circulation.
[6] M. Drazner,et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. , 2013, Journal of the American College of Cardiology.
[7] Sharon-Lise Normand,et al. Characteristics and Outcomes of Patients Receiving New and Replacement Implantable Cardioverter-Defibrillators: Results From the NCDR , 2013, Circulation. Cardiovascular quality and outcomes.
[8] I. Anand,et al. Incidence of appropriate shock in implantable cardioverter-defibrillator patients with improved ejection fraction. , 2013, Journal of cardiac failure.
[9] B. Lindsay,et al. ACCF/HRS/AHA/ASE/HFSA/SCAI/SCCT/SCMR 2013 appropriate use criteria for implantable cardioverter-defibrillators and cardiac resynchronization therapy: a report of the American College of Cardiology Foundation appropriate use criteria task force, Heart Rhythm Society, American Heart Association, Ameri , 2013, Journal of the American College of Cardiology.
[10] J. Messenger,et al. The National Cardiovascular Data Registry (NCDR) Data Quality Brief: the NCDR Data Quality Program in 2012. , 2012, Journal of the American College of Cardiology.
[11] P. Zimetbaum,et al. Time for a change--a new approach to ICD replacement. , 2012, The New England journal of medicine.
[12] K. Anstrom,et al. Linking the National Cardiovascular Data Registry CathPCI Registry With Medicare Claims Data: Validation of a Longitudinal Cohort of Elderly Patients Undergoing Cardiac Catheterization , 2012, Circulation. Cardiovascular quality and outcomes.
[13] M. Chung,et al. Complication Rates Associated With Pacemaker or Implantable Cardioverter-Defibrillator Generator Replacements and Upgrade Procedures: Results From the REPLACE Registry , 2010, Circulation.
[14] B. Lindsay,et al. Review of the Registry's second year, data collected, and plans to add lead and pediatric ICD procedures. , 2008, Heart rhythm.
[15] B. Lindsay,et al. Review of the registry's first year, data collected, and future plans. , 2007, Heart rhythm.
[16] C. Frampton,et al. B-Type Natriuretic Peptides and Ejection Fraction for Prognosis After Myocardial Infarction , 2003, Circulation.
[17] J. Fleiss,et al. Risk stratification and survival after myocardial infarction. , 1983, The New England journal of medicine.